How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making

Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force

Praveen Thokala, Nancy Devlin, Kevin Marsh et al. · Value in Health · 2016 · 685 citations · Full text

Nursing, Health Systems, Program Implementation +13

The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries

Angela Y. Chang, Carlos Riumalló‐Herl, Nicole Perales et al. · Health Affairs · 2018 · 82 citations · Full text

Averting Deaths, Economic Benefits, Health Disparities +23

The art of priority setting

Mireille Goetghebeur, Hector Castro-Jaramillo, Rob Baltussen et al. · The Lancet · 2017 · 28 citations

Engineering, Business, Algorithmic Mechanism Design +8

Challenges of vaccine presentation and delivery: How can we design vaccines to have optimal programmatic impact?

Birgitte Giersing, Anna-Léa Kahn, Courtney Jarrahian et al. · Vaccine · 2017 · 27 citations · Full text

Immunology, Vaccine Accessibility, Immunotherapy +24

‘It takes two to tango’: Bridging the gap between country need and vaccine product innovation

Rachel A. Archer, Ritika Kapoor, Wanrudee Isaranuwatchai et al. · PLoS ONE · 2020 · 11 citations · Full text